1,773
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Efficient synthesis, biological evaluation, and docking study of isatin based derivatives as caspase inhibitors

, , , , , , , , , ORCID Icon & show all
Pages 1674-1684 | Received 27 Aug 2019, Accepted 07 Aug 2020, Published online: 25 Aug 2020

Figures & data

Figure 1. Some of the reported caspase-3 inhibitors. IC50 = 120 nM; IC50 = 44 nM; IC50 = 2.5 nM. IC50 = 46.7µM; IC50 = 0.086 µM; IC50 = 0.031 µM

Figure 1. Some of the reported caspase-3 inhibitors. IC50 = 120 nM; IC50 = 44 nM; IC50 = 2.5 nM. IC50 = 46.7µM; IC50 = 0.086 µM; IC50 = 0.031 µM

Figure 2. 2 D and 3 D representations of 20d interactions with caspase-3 active site.

Figure 2. 2 D and 3 D representations of 20d interactions with caspase-3 active site.

Scheme 1. (A) Synthesis route for A series. Reagents and conditions. a: CH2Cl2, Et3N; b: NaH, DMF (B) Synthesis route for B series. Reagents and conditions. a: ClSO3H; b: pyrrolidine or 16, Et3N, DMF, c: acetic acid; d: 9 or propargyl bromide, NaH, DMF, 0 ˚C; e: p-toluenesulfonyl chloride, pyridine; f: phenol, NaH, THF; g: TFA, CH2Cl2.

Scheme 1. (A) Synthesis route for A series. Reagents and conditions. a: CH2Cl2, Et3N; b: NaH, DMF (B) Synthesis route for B series. Reagents and conditions. a: ClSO3H; b: pyrrolidine or 16, Et3N, DMF, c: acetic acid; d: 9 or propargyl bromide, NaH, DMF, 0 ˚C; e: p-toluenesulfonyl chloride, pyridine; f: phenol, NaH, THF; g: TFA, CH2Cl2.

Table 1. Structures of compounds 11a–k, 19a–k, and 20a–k displaying inhibitory effects on caspase-3 and -7.

Figure 3. Superimposition of the binding pose for 20d and natural ligand at the 1GFW active site.

Figure 3. Superimposition of the binding pose for 20d and natural ligand at the 1GFW active site.

Figure 4. 2 D representations of 20d (A) and isatin sulphonamide (B) interactions with caspase-3 active site.

Figure 4. 2 D representations of 20d (A) and isatin sulphonamide (B) interactions with caspase-3 active site.

Table 2. The interactions of compound 20d and natural ligand in 1GFW at the active site.